However, if we look at the total market, we see that out of the 4 biggest funding rounds in Femtech, 3 were raised by companies founded and built by men (Nurx, Hims/Hers, Ro/Rory). In fact, two of these four were initially men’s health companies, primarily selling on-demand pharma products, that then launched women-centered verticals (Hims/Hers, Ro... See more